?>
Contact us
Follow Us
About Us
Members
Executive Director
Why Biosimilars
The Issue
Our Solutions
Biosimilars 101
Foundations
Core Principles
FDA Regulatory Tenets
Biosimilars FAQs
Future Evolution of Biosimilar Development
Approved Biosimilars
Advocacy
Our Action
Tools
News
Resources
Get Involved
Partners
Archives:
Resources
Get more out of your business.
Reach it with Microsoft Dynamics 365 Business Central.
July 3, 2019
Katie Quinn
FDA Biosimilar Hub
July 3, 2019
Katie Quinn
Biologics Price Competition and Innovation Act of 2009
July 3, 2019
Katie Quinn
FDA Information on Prescribing Biosimilars
July 3, 2019
Katie Quinn
FDA Information on Prescribing Interchangeable Biosimilar Products
July 3, 2019
Katie Quinn
Biosimilars FAQs
July 3, 2019
Katie Quinn
Biosimilars Overview
July 3, 2019
Katie Quinn
Analysis Shows Biosimilars Lower Patient Costs
March 19, 2019
Katie Quinn
Structural Market Changes Needed to Achieve Cost-Savings from Biosimilars
October 3, 2018
Katie Quinn
Science-Based Resource on the Basic Facts About Biosimilars
01
02
03
04